These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 15022003

  • 1. [Statins-a panacea?].
    Klose G.
    Z Kardiol; 2004; 93 Suppl 1():I19-22. PubMed ID: 15022003
    [Abstract] [Full Text] [Related]

  • 2. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 4. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT.
    QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
    [Abstract] [Full Text] [Related]

  • 5. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P.
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [Abstract] [Full Text] [Related]

  • 6. [Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high].
    Einecke D.
    MMW Fortschr Med; 2004 Mar 25; 146(13):4-5. PubMed ID: 15219114
    [No Abstract] [Full Text] [Related]

  • 7. [Cholesterol: blood levels or total risk as a guide to preventive treatment?].
    Mathes P.
    Z Kardiol; 2004 Mar 25; 93 Suppl 2():II16-20. PubMed ID: 15021991
    [Abstract] [Full Text] [Related]

  • 8. [Fewer myocardial infarcts. Statin therapy is even effective in the elderly].
    MMW Fortschr Med; 2003 Mar 13; 145(11):58. PubMed ID: 12688200
    [No Abstract] [Full Text] [Related]

  • 9. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 13; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels.
    Tsevat J, Kuntz KM, Orav EJ, Weinstein MC, Sacks FM, Goldman L.
    Am Heart J; 2001 May 10; 141(5):727-34. PubMed ID: 11320359
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS, Bissonnette S, Habib R, Boukas S, Ezetrol Add-On Investigators.
    Ann Pharmacother; 2007 Sep 10; 41(9):1345-51. PubMed ID: 17666579
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
    Heintjes EM, Penning-van Beest FJ, Johansson S, Stalenhoef AF, Herings RM.
    Curr Med Res Opin; 2009 Nov 10; 25(11):2621-9. PubMed ID: 19743959
    [Abstract] [Full Text] [Related]

  • 16. [Prevention of coronary heart disease with statins. Which patients profit?].
    Adam O, Forth W.
    MMW Fortschr Med; 2003 Jun 19; 145(25):37-40. PubMed ID: 12891851
    [Abstract] [Full Text] [Related]

  • 17. Expected versus observed survival in 3 large population studies with HMG-CoA reductase inhibitors.
    Naslafkih A, Sestier F.
    J Insur Med; 2000 Jun 19; 32(3):155-62. PubMed ID: 15912915
    [Abstract] [Full Text] [Related]

  • 18. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
    März W.
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):53. PubMed ID: 15526673
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of hypercholesterolemia with statins].
    Erikssen J, Madsen S.
    Tidsskr Nor Laegeforen; 1997 Sep 20; 117(22):3216-20. PubMed ID: 9411860
    [Abstract] [Full Text] [Related]

  • 20. Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
    Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M.
    Circulation; 2004 Sep 21; 110(12):1557-63. PubMed ID: 15364796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.